Generating visualization...
Global Pharmaceutical Market Outlook Post-Patent Cliff.
This report provides an in-depth analysis of shifts in the global pharmaceutical market due to patent expirations occurring from 2023 to 2030. It examines how these changes impact revenue, particularly focusing on biosimilars and generics, affecting key therapy areas such as oncology and immunology. The report discusses geographical impacts across regions like North America, Europe, Asia-Pacific, and more, while highlighting strategic responses from major pharmaceutical companies. Lastly, it explores the regulatory implications and strategies for industry stakeholders to adapt to the evolving market landscape.
BiosimilarsDrug ExpiryMarket StrategyPatent CliffPharmaceutical ForecastsPharmaceutical Market
Plabani Ghosh, Ghost Research
2026-01-02
Feedback
Limited Time Offer
$50$150
(exclusive of tax)Single User License© 2025 Caspr Research Private Limited
63Pages of Deep Analysis
31Credible Sources Referenced
13Data Analysis Tables
9Proprietary AI Visuals
Plabani Ghosh
6+ Years of Experience
Sectors & Industries
Consumer GoodsIndustrial
Functions & Expertise
Market IntelligenceStrategic ConsultingCompetitive Benchmarking
+3
Perspective.
PurposeTo analyze the impact of patent expirations on the global pharmaceutical market and provide strategic insights for stakeholders.
AudiencePharmaceutical companies, policymakers, investors, and healthcare professionals.
Report LengthComprehensive analysis covering numerous aspects of the global pharmaceutical market.
Focus Areas.
Industries JobsPharmaceutical industry, drug development, regulatory and market strategies.
Geographic AreasGlobal focus, with emphasis on North America, Europe, Asia-Pacific, Latin America, Middle East & Africa.
Special EmphasisEmphasis on market dynamics, policy implications, strategic adaptations, and innovation.
Report Layout.
Introduction to the Patent Cliff Challenge
- Definition and scope
- Historical comparison
- Revenue at risk
- Therapeutic areas impact
Get the Insights You Need — Download Now.
Insights.
Patent cliff between 2025 and 2030 threatens significant revenue loss in the pharmaceutical industry.The global market is projected to grow from USD 1.65 trillion in 2024 to USD 2.35 trillion by 2030.Biosimilars and generics are gaining traction, reshaping market dynamics and industry strategies.Strategic responses include portfolio diversification, lifecycle management, and geographic growth.Policy reforms are critical, with emphasis on cost-containment and regulatory streamlining.Key Questions Answered.
